Neuehealth Stock Investor Sentiment
| NEUE Stock | 5.08 1.55 23.38% |
About 56% of NeueHealth's investor base is looking to short. The analysis of overall sentiment of trading NeueHealth stock suggests that many investors are alarmed at this time. The current market sentiment, together with NeueHealth's historical and current headlines, can help investors time the market. In addition, many technical investors use NeueHealth stock news signals to limit their universe of possible portfolio assets.
NeueHealth |
NeueHealth Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards NeueHealth can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about NeueHealth that are available to investors today. That information is available publicly through NeueHealth media outlets and privately through word of mouth or via NeueHealth internal channels. However, regardless of the origin, that massive amount of NeueHealth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NeueHealth news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NeueHealth relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NeueHealth's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NeueHealth alpha.
NeueHealth Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 16803 shares by Mikan George Lawrence Iii of NeueHealth at 4.18 subject to Rule 16b-3 | 12/17/2024 |
2 | SHAREHOLDER ALERT The MA Class Action Firm Investigates the Merger of NeueHealth, Inc. - NEUE | 12/30/2024 |
3 | Acquisition by New Enterprise Associates 15, L.p. of 61865 shares of NeueHealth at 0.01 subject to Rule 16b-3 | 01/08/2025 |
4 | SHAREHOLDER NOTICE Halper Sadeh LLC Investigates LBRDA, OMIC, NEUE, RSLS on Behalf of Shareholders | 01/28/2025 |
5 | SHAREHOLDER ALERT The MA Class Action Firm Continues To Investigate The Merger - AVAV, ... | 02/07/2025 |
6 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates NEUE, ESSA, LTRPA on Behalf of Shareholders | 02/10/2025 |
7 | SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Investors of an Investigation into ... | 02/12/2025 |
8 | Disposition of 317 shares by Jay Matushak of NeueHealth at 6.05 subject to Rule 16b-3 | 02/21/2025 |
9 | Disposition of 58877 shares by Mikan George Lawrence Iii of NeueHealth subject to Rule 16b-3 | 03/06/2025 |
10 | Disposition of 4755 shares by Kadre Manuel of NeueHealth subject to Rule 16b-3 | 03/07/2025 |
11 | Disposition of 1604 shares by Mikan George Lawrence Iii of NeueHealth at 7.06 subject to Rule 16b-3 | 03/10/2025 |
12 | Disposition of 3747 shares by Mikan George Lawrence Iii of NeueHealth at 6.85 subject to Rule 16b-3 | 03/11/2025 |
13 | Insider Selling NeueHealth, Inc. CFO Sells 1,860 Shares of Stock | 03/12/2025 |
14 | NeueHealth, Inc. CEO George Lawrence Mikan III Sells 13,180 Shares | 03/14/2025 |
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |